{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T20:21:34Z","timestamp":1775161294938,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T00:00:00Z","timestamp":1664755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Currently, all researchers are concentrating their efforts on countering the COVID-19 pandemic. The majority of patients are managed at home, according to recent statistics. An OTC triple action combination comprising paracetamol (PAR), aspirin (ASP), and diphenhydramine (DIPH) is commonly given for pain relief, fever control, and as a night-time sleep aid. This combination is currently recommended for COVID-19 patients as part of symptomatic treatment and management. In this work, three smart, simple, accurate, eco-friendly, and cost-effective spectrophotometric methods are developed for simultaneous determination of PAR, ASP, and DIPH in their combined over-the-counter caplet dosage form without any prior separation steps. The first method is the first derivative spectrophotometry (D<jats:sup>1<\/jats:sup>) which determined PAR at 259.7\u00a0nm. The second one is the dual-wavelength in ratio spectra (DWRS) for determination of ASP at 214.1 and 220.1\u00a0nm after using 10.0\u00a0\u03bcg\/mL of PAR as a divisor, where PAR was a constant, and the wavelengths difference equal to zero for DIPH. The third method is the double divisor-ratio difference spectrophotometric one (DD-RD) which was based on using the sum of 15.0\u00a0\u00b5g\/mL of each of PAR and ASP as a double divisor, and the difference in amplitudes was measured at two wavelengths \u2206P<jats:sub>(214.5\u2013226.0)<\/jats:sub> for determination of DIPH. The developed methods have been validated as per ICH guidelines. Furthermore, the three suggested methods were employed successfully to assay marketed pharmaceutical formulation and to investigate the content uniformity of the dosage units in accordance with the United States Pharmacopeia's guidelines. Finally, the greenness profile\u00a0of the proposed methods was assessed and compared with the reported method\u00a0using the analytical eco-scale system, national environmental method index (NEMI), green analytical procedure index (GAPI), and analytical greenness (AGREE) metric. The results from the proposed methods statistically agreed with those obtained by the reported one, with no significant differences in accuracy and precision.<\/jats:p>\n                <jats:p><jats:bold>Graphical Abstract<\/jats:bold><\/jats:p>","DOI":"10.1186\/s13065-022-00868-0","type":"journal-article","created":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T15:02:37Z","timestamp":1664809357000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Eco-friendly resolution of spectrally overlapping signals of a combined triple-action over-the-counter pharmaceutical formulation for symptomatic management of COVID-19 pandemic: application to content uniformity testing"],"prefix":"10.1186","volume":"16","author":[{"given":"Hoda M.","family":"Marzouk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Engy A.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha A.","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samah S.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,3]]},"reference":[{"key":"868_CR1","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.saa.2018.07.018","volume":"205","author":"HI El-Shorbagy","year":"2018","unstructured":"El-Shorbagy HI, Elsebaei F, Hammad SF, Elbrashy AM. Earth-friendly spectrophotometric methods for simultaneous determination of ledipasvir and sofosbuvir: application to average content and uniformity of dosage unit testing. Spectrochim Acta A Mol Biomol Spectrosc. 2018;205:398\u2013409.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"868_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.saa.2019.01.058","volume":"213","author":"MR Rezk","year":"2019","unstructured":"Rezk MR, Monir HH, Marzouk HM. Spectrophotometric assessment of the brand new antiviral combination: sofosbuvir and velpatasvir in their pure forms and pharmaceutical formulation. Spectrochim Acta A Mol Biomol Spectrosc. 2019;213:159\u201366.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"868_CR3","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.chroma.2006.10.067","volume":"1156","author":"B B\u00e1nfai","year":"2007","unstructured":"B\u00e1nfai B, Ganzler K, Kem\u00e9ny S. Content uniformity and assay requirements in current regulations. J Chromatogr A. 2007;1156:206\u201312.","journal-title":"J Chromatogr A"},{"key":"868_CR4","first-page":"2295","volume":"5","author":"V Abbirami","year":"2013","unstructured":"Abbirami V, Sainithya P, Shobana A, Ramya Devi D, Vedha Hari BN. A review on in-vitro bioequivalence studies and its methodologies. Int J ChemTech Res. 2013;5:2295\u2013302.","journal-title":"Int J ChemTech Res"},{"key":"868_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.saa.2022.121063","volume":"273","author":"Y Rostom","year":"2022","unstructured":"Rostom Y, Wadie M, Rezk MR, Marzouk HM, Abdel-Moety EM. Fingerprinting and iso-absorptive resolution techniques for the spectrally overlapping Dutasteride and Silodosin mixture: content uniformity testing along with greenness profile assessment. Spectrochim Acta A Mol Biomol Spectrosc. 2022;273:1\u201313.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"868_CR6","unstructured":"British Pharmacopoeia Commission, London, Her Majesty\u2019s Stationery Office. 2016."},{"key":"868_CR7","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1002\/jmv.27158","volume":"93","author":"S Pandolfi","year":"2021","unstructured":"Pandolfi S, Simonetti V, Ricevuti G, Chirumbolo S. Paracetamol in the home treatment of early COVID-19 symptoms: a possible foe rather than a friend for elderly patients. J Med Virol. 2021;93:5704\u20136.","journal-title":"J Med Virol"},{"key":"868_CR8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbrc.2020.11.095","volume":"538","author":"LR Reznikov","year":"2021","unstructured":"Reznikov LR, Norris MH, Vashisht R, Bluhm AP, Li D, Liao YSJ, Brown A, Butte AJ, Ostrov DA. Identification of antiviral antihistamines for COVID-19 repurposing. Biochem Biophys Res Commun. 2021;538:173\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"868_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcvm.2020.562708","volume":"7","author":"T Diaz","year":"2020","unstructured":"Diaz T, Trachtenberg BH, Abraham SJK, KosagiSharaf R, Durant-Archibold AA. Aspirin bioactivity for prevention of cardiovascular injury in COVID-19. Front Cardiovasc Med. 2020;7:1\u20134.","journal-title":"Front Cardiovasc Med"},{"key":"868_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.microc.2022.107400","volume":"178","author":"HM Marzouk","year":"2022","unstructured":"Marzouk HM, Ibrahim EA, Hegazy MA, Saad SS. Sustainable liquid chromatographic determination and purity assessment of a possible add-on triple-action over-the-counter pharmaceutical combination in COVID-19. Microchem J. 2022;178:1\u20138.","journal-title":"Microchem J"},{"key":"868_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1039\/B918763B","volume":"39","author":"P Anastas","year":"2010","unstructured":"Anastas P, Eghbali N. Green chemistry: principles and practice. Chem Soc Rev. 2010;39:301\u201312.","journal-title":"Chem Soc Rev"},{"key":"868_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.microc.2020.104893","volume":"157","author":"D Mohamed","year":"2020","unstructured":"Mohamed D, Hegazy MA, El-Sayed GM, Youssef SH. Greenness evaluation of different chromatographic approaches for the determination of dextromethorphan, phenylephrine & brompheniramine in their pharmaceutical formulation. Microchem J. 2020;157: 104893.","journal-title":"Microchem J"},{"key":"868_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/bmc.5132","volume":"35","author":"HM Marzouk","year":"2021","unstructured":"Marzouk HM, Ibrahim EA, Hegazy MA, Saad SS. Greenness profile assessment of selective liquid chromatographic methods for determination of a quaternary antimigraine combination along with three of their related official impurities. Biomed Chromatogr. 2021;35:1\u201311.","journal-title":"Biomed Chromatogr"},{"key":"868_CR14","first-page":"1","volume":"29","author":"S El-Hanboushy","year":"2022","unstructured":"El-Hanboushy S, Marzouk HM, Fayez YM, Abdelkawy M, Lotfy HM. Sustainable spectrophotometric determination of antihypertensive medicines reducing COVID-19 risk via paired wavelength data processing technique\u2014assessment of purity, greenness and whiteness. Sustain Chem Pharm. 2022;29:1\u201316.","journal-title":"Sustain Chem Pharm"},{"key":"868_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.saa.2022.121523","volume":"280","author":"S El-Hanboushy","year":"2022","unstructured":"El-Hanboushy S, Marzouk HM, Fayez YM, Abdelkawy M, Lotfy HM. Eco-friendly spectrophotometric evaluation of triple-combination therapies in the treatment strategy of patients suffering from hypertension during coronavirus pandemic\u2014spectralprint recognition study. Spectrochim Acta A Mol Biomol Spectrosc. 2022;280:1\u201315.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"868_CR16","unstructured":"The United States Pharmacopeia and The National Formulary. Rockville MD, USA: USP 42-NF 37, U.S. Pharmacopeial Convention. 2019."},{"key":"868_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/jps.2600690605","volume":"69","author":"J Traveset","year":"1980","unstructured":"Traveset J, Such V, Gonzalo R, Gelpi E. Derivative and graphical procedures for correction of irrelevant UV spectrophotometric absorption in changeable matrixes. J Pharm Sci. 1980;69:629\u201333.","journal-title":"J Pharm Sci"},{"key":"868_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.saa.2015.03.095","volume":"147","author":"AS Saad","year":"2015","unstructured":"Saad AS. Novel spectrophotometric method for selective determination of compounds in ternary mixtures (dual wavelength in ratio spectra). Spectrochim Acta A Mol Biomol Spectrosc. 2015;147:757\u201361.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"868_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.saa.2012.04.096","volume":"95","author":"ES Elzanfaly","year":"2012","unstructured":"Elzanfaly ES, Saad AS, Abd-Elaleem A-EB. Combining the isoabsorptive point in the ratio spectrum and the smart ratio difference methods for a single step determination of compounds with overlapped spectra. Spectrochim Acta Part A Mol Biomol Spectrosc. 2012;95:188\u201392.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"868_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jsps.2012.03.004","volume":"20","author":"ES Elzanfaly","year":"2012","unstructured":"Elzanfaly ES, Saad AS, Abd-Elaleem A-EB. Simultaneous determination of retinoic acid and hydroquinone in skin ointment using spectrophotometric technique (ratio difference method). Saudi Pharm J. 2012;20:249\u201353.","journal-title":"Saudi Pharm J"},{"key":"868_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.saa.2012.04.095","volume":"96","author":"HM Lotfy","year":"2012","unstructured":"Lotfy HM, Hagazy MA-M. Comparative study of novel spectrophotometric methods manipulating ratio spectra: an application on pharmaceutical ternary mixture of omeprazole, tinidazole and clarithromycin. Spectrochim Acta Part A Mol Biomol Spectrosc. 2012;96:259\u201370.","journal-title":"Spectrochim Acta Part A Mol Biomol Spectrosc"},{"key":"868_CR22","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/j.saa.2014.09.055","volume":"137","author":"AA Moustafa","year":"2015","unstructured":"Moustafa AA, Salem H, Hegazy M, Ali O. Evaluating the efficiency of spectral resolution of univariate methods manipulating ratio spectra and comparing to multivariate methods: an application to ternary mixture in common cold preparation. Spectrochim Acta A Mol Biomol Spectrosc. 2015;137:1363\u201373.","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"},{"key":"868_CR23","unstructured":"ICH harmonized tripartite guideline, Validation of analytical procedures: text and methodology Q2 (R1). 2005."},{"key":"868_CR24","unstructured":"U.S. Pharmacopoeial Convention, (905) Uniformity of dosage units. Stage 6 harmonization. 2011."},{"key":"868_CR25","doi-asserted-by":"publisher","first-page":"10928","DOI":"10.3390\/molecules200610928","volume":"20","author":"M Tobiszewski","year":"2015","unstructured":"Tobiszewski M, Mar\u0107 M, Ga\u0142uszka A, Namie\u015bnik J. Green chemistry metrics with special reference to green analytical chemistry. Molecules. 2015;20:10928\u201346.","journal-title":"Molecules"},{"key":"868_CR26","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/jssc.201401151","volume":"38","author":"ES Elzanfaly","year":"2015","unstructured":"Elzanfaly ES, Hegazy MA, Saad SS, Salem MY, Abd El Fattah LE. Validated green high-performance liquid chromatographic methods for the determination of coformulated pharmaceuticals: a comparison with reported conventional methods. J Sep Sci. 2015;38:757\u201363.","journal-title":"J Sep Sci"},{"key":"868_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","volume":"37","author":"A Ga\u0142uszka","year":"2012","unstructured":"Ga\u0142uszka A, Migaszewski ZM, Konieczka P, Namie\u015bnik J. Analytical eco-scale for assessing the greenness of analytical procedures. TrAC Trends Anal Chem. 2012;37:61\u201372.","journal-title":"TrAC Trends Anal Chem"},{"key":"868_CR28","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1021\/cr068359e","volume":"107","author":"LH Keith","year":"2007","unstructured":"Keith LH, Gron LU, Young JL. Green analytical methodologies. Chem Rev. 2007;107:2695\u2013708.","journal-title":"Chem Rev"},{"key":"868_CR29","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1039\/C6AY00478D","volume":"8","author":"M Tobiszewski","year":"2016","unstructured":"Tobiszewski M. Metrics for green analytical chemistry. Anal Methods. 2016;8:2993\u20139.","journal-title":"Anal Methods"},{"key":"868_CR30","unstructured":"Emergency Planning and Community Right-to-Know Act; Section 313 Toxic Release Inventory (TRI) Chemical List for Reporting Year 2019. United States Environmental Protection Agency. 2019. p. 1\u201326. https:\/\/www.epa.gov\/sites\/default\/files\/2020-02\/documents\/ry_2019_tri_chemical_list_0.pdf. Accessed 2 July 2022."},{"key":"868_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","volume":"181","author":"J P\u0142otka-Wasylka","year":"2018","unstructured":"P\u0142otka-Wasylka J. A new tool for the evaluation of the analytical procedure: green analytical procedure index. Talanta. 2018;181:204\u20139.","journal-title":"Talanta"},{"key":"868_CR32","doi-asserted-by":"publisher","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","volume":"92","author":"F Pena-Pereira","year":"2020","unstructured":"Pena-Pereira F, Wojnowski W, Tobiszewski M. AGREE\u2014Analytical GREEnness Metric Approach and Software. Anal Chem. 2020;92:10076\u201382.","journal-title":"Anal Chem"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-022-00868-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-022-00868-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-022-00868-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T15:03:33Z","timestamp":1664809413000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-022-00868-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,3]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1186\/s13065-022-00868-0","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,3]]},"assertion":[{"value":"6 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"73"}}